Public Wary of Faster Approvals of New Drugs, STAT-Harvard Poll Finds

Interviews Conducted by SSRS

“The majority of Americans opposes federal regulatory changes to speed up the development and approval of new medical treatments, a new STAT-Harvard poll finds — suggesting the public has serious doubts about legislation now moving through Congress.”

This survey was conducted for STAT and Harvard T.H. Chan School of Public Health via telephone by SSRS. Interviews were conducted via telephone (cell phone and landline) April 27 –May 1, 2016,among a nationally representative sample of 1,006 U.S. adults. The margin of error for total respondents is +/-3.6 percentage points at the 95% confidence level.